Bionaut Labs is focused on revolutionizing the treatment of central nervous system disorders with its Bionaut™ precision medicine treatment modality that uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted disease areas. With the Bionaut™ medical modality, Bionaut Labs can transform the way the biopharmaceutical industry develops treatments, allowing the Company to engineer the therapeutic index for better efficacy and safety. Led by a world-class team of medical, engineering, and drug development experts, Bionaut Labs' headquarters is in Los Angeles, California, with additional R&D sites in Israel and at the Max Planck Institute in Germany.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/04/21 | $20,000,000 | Seed |
Bold Capital Compound Revolution LLC Upfront Ventures | undisclosed |
| 11/28/22 | $43,200,000 | Series B |
Bold Capital Compound Deep Insight Dolby Family Ventures Gaingels GISEV Family Office OurCrowd PSPRS Revolution Ventures Sixty Degree Capital Tintah Grace Upfront Ventures What If Ventures | undisclosed |
